Another clinical implication of the present findings is that elevated CLR levels indicate a severe imbalance between the inflammation response and the immune defense function; therefore, treatment of inflammation-immune disorders by targeting CRP or lymphocytes may have the potential to improve the prognosis of aSAH patients. This evidence concerns the gene CRP and immune system disorder.